InHLWF℠ AlliancebyDori Gonzalez-Acevedo | CEO and Founder·Feb 7, 2024Confronting the Hidden Enemies: Coercive Bias and Bureaucracy in CSVIs Your Organizational Culture a Competitive Advantage or a Roadblock? Rethinking Coercive Bias and Bureaucracy for the FutureA response icon2A response icon2
InTerri Hanson MeadbyTerri Hanson Mead·Sep 27, 2023Right-Sizing Computer Validation in Life SciencesMost life sciences companies struggle to find the right balance when validating their computer and enterprise systems. They struggle to see…
InTerri Hanson MeadbyTerri Hanson Mead·Apr 26, 2023IT SOPs for Controlled Systems in Life SciencesEmerging life sciences companies often select a quality system (document management, deviations/NCMRs, CAPAs) or an ERP system (accounting…
InTerri Hanson MeadbyTerri Hanson Mead·Oct 27, 2022Are You a SaaS Company Looking for a Piece of the Life Sciences Action?I’ve received a few inquiries lately from SaaS vendors interested in selling into life sciences. They see the big dollars in the sector and…
InTerri Hanson MeadbyTerri Hanson Mead·Oct 27, 2022SaaS Vendors’ CSA/CSV Responsibilities in Life SciencesI’ve leveraged a practical approach to computer validation (CSV which is now CSA) for nearly two decades. I’ve relied on GAMP5 and in…
InTerri Hanson MeadbyTerri Hanson Mead·Feb 21, 2021Google Cloud Platform (GCP) in Life Sciences: Qualifying the Cloud (IaaS/PaaS)Moving to the Cloud in Life Sciences
InTerri Hanson MeadbyTerri Hanson Mead·Jan 15, 2021Microsoft Azure in Life Sciences: Qualifying the Cloud (IAAS / PAAS)Moving to the Cloud in Life Sciences
InTerri Hanson MeadbyTerri Hanson Mead·Jun 13, 2018Modern Approach to System Selection (Part 1 of 2)We live in a time where we can order groceries from Alexa, get directions from Siri and use Google to make hotel reservations. With so much…
InTerri Hanson MeadbyTerri Hanson Mead·Jan 17, 2018Failed IT Implementations are Expensive: Here’s How to Avoid ThemBy Terri Hanson Mead
InTerri Hanson MeadbyTerri Hanson Mead·Jan 17, 2018SaaS Adoption Will Lead to Compliance Issues for Life Sciences CompaniesNo Panacea
